Kerri St. Denis

Yale University — United States

Medicine · Health Sciences

22h-index4.5kcitations44works17.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(40), COVID-19 Clinical Research Studies(13), Viral gastroenteritis research and epidemiology(10), Vaccine Coverage and Hesitancy(8), Viral Infections and Immunology Research(6)

Publications44 total

CD8 T cells mediate immunosurveillance for neoantigen+ epithelial stem cells in the colon
2025
Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity
Cell Reports Medicine·2024· 13 citedOpen Access
Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity
2024· 3 citedOpen Access
Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds
Nature Communications·2024· 71 citedOpen Access
Heterologous Sarbecovirus Receptor Binding Domains as Scaffolds for SARS-CoV-2 Receptor Binding Motif Presentation
ACS Infectious Diseases·2024Open Access
Heterologous sarbecovirus receptor binding domains as scaffolds for SARS-CoV-2 receptor binding motif presentation
2023Open Access
Diagnostic TR-FRET assays for detection of antibodies in patient samples
Cell Reports Methods·2023· 6 citedOpen Access
SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine — Ohio and Rhode Island, September–November 2022
MMWR Morbidity and Mortality Weekly Report·2023· 26 citedOpen Access
BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children
npj Vaccines·2022· 12 citedOpen Access
Cross-reactive SARS-CoV-2 epitope targeted across donors informs immunogen design
Cell Reports Medicine·2022· 8 citedOpen Access
Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds
2022· 20 citedOpen Access
SARS-CoV-2 mRNA vaccination elicits robust antibody responses in children
Science Translational Medicine·2022· 44 citedOpen Access
BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children
2022· 2 citedOpen Access
COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents
EBioMedicine·2022· 49 citedOpen Access
Response to Severe Acute Respiratory Syndrome Coronavirus 2 Initial Series and Additional Dose Vaccine in Patients With Predominant Antibody Deficiency
The Journal of Allergy and Clinical Immunology In Practice·2022· 22 citedOpen Access
Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children
Vaccines·2022· 17 citedOpen Access
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals
Cell·2022· 65 citedOpen Access
Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting
Cell Reports·2022· 33 citedOpen Access
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals
Cell·2022· 253 citedOpen Access
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
Cell·2022· 1.1k citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Alejandro B. Balazs(41), Evan C. Lam(34), Blake M. Hauser(16), Aaron G. Schmidt(16), Wilfredo F. García-Beltrán(15), Vivek Naranbhai(15), Jared Feldman(14), A. John Iafrate(14), Maegan L. Sheehan(13), David J. Gregory(11), Mark C. Poznansky(11), David H. Canaday(10), Stefan Gravenstein(10), Daniel Lingwood(10), Onosereme Ofoman(9), Oladayo A. Oyebanji(8), Debbie Keresztesy(8), Dennis Wilk(8), Brigid Wilson(8), Christopher L. King(8)